These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29107186)

  • 1. A bell-shaped dependence between amyloidosis and GABA accumulation in astrocytes in a mouse model of Alzheimer's disease.
    Brawek B; Chesters R; Klement D; Müller J; Lerdkrai C; Hermes M; Garaschuk O
    Neurobiol Aging; 2018 Jan; 61():187-197. PubMed ID: 29107186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease.
    Roy U; Stute L; Höfling C; Hartlage-Rübsamen M; Matysik J; Roβner S; Alia A
    Neurobiol Aging; 2018 Feb; 62():168-179. PubMed ID: 29154037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model.
    Wu Z; Guo Z; Gearing M; Chen G
    Nat Commun; 2014 Jun; 5():4159. PubMed ID: 24923909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease.
    Andersen JV; Christensen SK; Westi EW; Diaz-delCastillo M; Tanila H; Schousboe A; Aldana BI; Waagepetersen HS
    Neurobiol Dis; 2021 Jan; 148():105198. PubMed ID: 33242587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; Malester B; LaFrancois J; Zehr C; Daeschner JM; Olschowka JA; Fonseca MI; O'Banion MK; Tenner AJ; Lemere CA; Duff K
    Am J Pathol; 2001 Apr; 158(4):1345-54. PubMed ID: 11290552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease.
    Jo S; Yarishkin O; Hwang YJ; Chun YE; Park M; Woo DH; Bae JY; Kim T; Lee J; Chun H; Park HJ; Lee DY; Hong J; Kim HY; Oh SJ; Park SJ; Lee H; Yoon BE; Kim Y; Jeong Y; Shim I; Bae YC; Cho J; Kowall NW; Ryu H; Hwang E; Kim D; Lee CJ
    Nat Med; 2014 Aug; 20(8):886-96. PubMed ID: 24973918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
    Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
    J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.
    Salcedo C; Wagner A; Andersen JV; Vinten KT; Waagepetersen HS; Schousboe A; Freude KK; Aldana BI
    Neurochem Res; 2021 Oct; 46(10):2676-2686. PubMed ID: 33710537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AQP4 Association with Amyloid Deposition and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer's Disease.
    Yang J; Zhang R; Shi C; Mao C; Yang Z; Suo Z; Torp R; Xu Y
    J Alzheimers Dis; 2017; 57(1):157-169. PubMed ID: 28222512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
    Cai Y; Xue ZQ; Zhang XM; Li MB; Wang H; Luo XG; Cai H; Yan XX
    Neuroscience; 2012 Jul; 215():160-73. PubMed ID: 22542680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine synthetase in astrocytes from entorhinal cortex of the triple transgenic animal model of Alzheimer's disease is not affected by pathological progression.
    Yeh CY; Verkhratsky A; Terzieva S; Rodríguez JJ
    Biogerontology; 2013 Dec; 14(6):777-87. PubMed ID: 23990215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer's disease.
    Alberdi E; Wyssenbach A; Alberdi M; Sánchez-Gómez MV; Cavaliere F; Rodríguez JJ; Verkhratsky A; Matute C
    Aging Cell; 2013 Apr; 12(2):292-302. PubMed ID: 23409977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.
    Kimbrough IF; Robel S; Roberson ED; Sontheimer H
    Brain; 2015 Dec; 138(Pt 12):3716-33. PubMed ID: 26598495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
    Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
    Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease.
    Nilsen LH; Witter MP; Sonnewald U
    J Cereb Blood Flow Metab; 2014 May; 34(5):906-14. PubMed ID: 24594625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
    Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
    Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.